NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 919 filers reported holding NOVARTIS A G in Q4 2015. The put-call ratio across all filers is 1.61 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $879,000 | -4.2% | 11,129 | 0.0% | 0.05% | -4.1% |
| Q2 2016 | $918,000 | +3.0% | 11,129 | -9.5% | 0.05% | +4.3% |
| Q1 2016 | $891,000 | +2.2% | 12,299 | +21.3% | 0.05% | -7.8% |
| Q4 2015 | $872,000 | -6.4% | 10,136 | 0.0% | 0.05% | -13.6% |
| Q3 2015 | $932,000 | -6.5% | 10,136 | 0.0% | 0.06% | +11.3% |
| Q2 2015 | $997,000 | -0.3% | 10,136 | 0.0% | 0.05% | 0.0% |
| Q1 2015 | $1,000,000 | -0.5% | 10,136 | -6.5% | 0.05% | -3.6% |
| Q4 2014 | $1,005,000 | -1.6% | 10,846 | 0.0% | 0.06% | -3.5% |
| Q3 2014 | $1,021,000 | -3.3% | 10,846 | -7.0% | 0.06% | -1.7% |
| Q2 2014 | $1,056,000 | -1.1% | 11,666 | -7.1% | 0.06% | -4.9% |
| Q1 2014 | $1,068,000 | +5.8% | 12,556 | 0.0% | 0.06% | +17.3% |
| Q4 2013 | $1,009,000 | +20.0% | 12,556 | +14.6% | 0.05% | +8.3% |
| Q3 2013 | $841,000 | +8.5% | 10,959 | 0.0% | 0.05% | +2.1% |
| Q2 2013 | $775,000 | – | 10,959 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PRENTISS SMITH & CO INC | 127,510 | $11,721,000 | 6.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 127,716 | $11,740,000 | 6.04% |
| EXENCIAL WEALTH ADVISORS, LLC | 116,917 | $10,747,000 | 5.25% |
| MCDANIEL TERRY & CO | 181,095 | $16,646,000 | 4.64% |
| Fayerweather Charles | 18,180 | $1,671,000 | 4.54% |
| Osher Van de Voorde Investment Management | 78,138 | $7,182,000 | 4.38% |
| BROWN BROTHERS HARRIMAN & CO | 9,291,495 | $854,074,000 | 4.35% |
| Boulegeris Investments, Inc. | 61,322 | $5,637,000 | 4.31% |
| DODGE & COX | 45,723,035 | $4,202,861,000 | 4.23% |
| WHV Investments, Inc. | 1,603,476 | $152,945,000 | 4.23% |